The Swiss government meets pharmaceutical giants to discuss American customs duties

Furthermore,

Swiss government meets pharmaceutical giants new: Similarly. Therefore. Consequently,

Swiss government meets pharmaceutical giants:

The Swiss government is to meet this week of pharmaceutical companies this week to which US President Donald Trump has asked to lower their prices. Furthermore, while Switzerland seeks to decrease a new customs tariff by 39 % on its exports, two sources told Reuters.

The Minister of the Economy Guy Parmelin. Nevertheless. Therefore. Similarly, the Minister of Health Elisabeth Baume-Schneider will meet leaders of Roche and Novartis, according to two people close to the file, who specify that other companies could also participate in the meeting.

Roche and Novartis did not respond to requests for comments.

A spokesman for the Minister of Health confirmed the meeting of the meeting. Therefore, but refused to give details or confirm the identity of the participants.

Although pharmaceutical products are not included in the American customs swiss government meets pharmaceutical giants new duties of swiss government meets pharmaceutical giants new 39. Moreover, % which came into force last. However, Additionally, Therefore, week on swiss government meets pharmaceutical giants Swiss imports. the sector is worried about the outcome of the American national security survey (section 232) concerning this field. This could lead to customs duties on imports of drugs reaching up to 250 %.

The results of this revision are expected in the coming weeks.

Discussions could also relate to the incitement of pharmaceutical companies to invest more in the United States. according to a source close to the file. in order to reduce the Swiss trade surplus with the United States. to help reduce the rate by 39 %, which concerns in particular the exports of Swiss watches and chocolate.

Donald Trump puts pressure on pharmaceutical groups to drop the price of their medicines in the United States. which could encourage laboratories swiss government meets pharmaceutical giants new to increase their prices in Europe to compensate.

Such swiss government meets pharmaceutical giants new a measure worried about the Swiss Ministry of Health. which sets the prices of drugs with swiss government meets pharmaceutical giants pharmaceutical companies because it could make drugs. more expensive in Switzerland. while their prices are already slightly higher than that of other European countries.

The Swiss government had previously indicated that helene Budliger Artieda. its main negotiator. head of the State Secretariat for the Economy (SECO). had returned from Washington, but that discussions on customs duties with the United States continued.

The pharmaceutical sector remains by far the first Swiss exporter sector to the United States, with shipments worth 32.75 billion Swiss francs, representing half of the Swiss exports to this country last year.

If the rate of 39 % was to apply to pharmaceuticals. Swiss economic production could fall by more than 1 swiss government meets pharmaceutical giants new %, according to an estimate.

Washington’s concerns are fueled by a commercial deficit of 38.7 swiss government meets pharmaceutical giants new billion francs with Switzerland, largely due to the pharmaceutical sector.

Swiss companies. especially in the Pharma. have already committed to swiss government meets pharmaceutical giants increasing their investments in the United States to avoid customs duties.

In April. Novartis announced its intention to invest $ 23 billion to build. enlarge ten sites in the United States. while Roche unveiled an investment plan of $ 50 billion over the next five years, creating more than 12,000 new jobs.

(Report by John Revill. edited by Philippa Fletcher)

Swiss government meets pharmaceutical giants new

Swiss government meets pharmaceutical giants new

Swiss government meets pharmaceutical giants

Further reading: The Calmann-Lévy family requests that Fayard. the “JDD” and Europe 1 be taken up live by the Bolloré groupPay more expensive for an ecological swiss government meets pharmaceutical giants new house, a decision that is worth the “cost”?When artificial intelligence lies. trading: here are 5 examples of real behaviors that are scary swiss government meets pharmaceutical giants new – Paris: takes his breath before an avalanche of results – 07/21/2025 at 11:02This source water contains a bacteria: do not drink it anymore.

Further reading: The 5 models that arrive by the end of the year and that are worth waitingNew models, margins, international expansion … François Provost, new boss of Renault, reveals his prioritiesTaxes: these French cities where the property tax is very high for new owners: NewsTrump threatens to raise prices if Europe does not give it $ 600 billion to invest in &#8220. Absolutely everything he wants”How much do you really save by borrowing nationals rather than highways?.

swiss government meets pharmaceutical giants new

Further reading: The ECB maintains its unchanged ratesThe New York Stock Exchange carried by AppleLVMH: why Hermès gives in to LVMH its crown of first capitalization of the Paris Stock ExchangeSwiss businessman Éric Freymond committed suicideA third place to return to Trois-Rivières.

Comments (0)
Add Comment